Micronisation of simvastatin by the supercritical antisolvent technique: in vitro–in vivo evaluation

References

• Ambike AA, Mahadik KR, Paradkar A. Spray-dried amorphous solid dispersions of simvastatin, a low TG drug; in vitro and in vivo evaluations. Pharm Res, 2005;22:990–8
   PubMed Web of Science ®Google Scholar
• Bristow S, Shekunov T, Shekunov BY, York P. Analysis of the supersaturation and precipitation process with supercritical CO2. J Supercrit Fluids, 2001;21:257–71
   Web of Science ®Google Scholar
• Chavhan S, Joshi G, Petkar K, Sawant K. Enhanced bioavailability and hypolipidemic activity of simvastatin formulations by particle size engineering: Physicochemical aspects and in vivo investigations. Bio Eng J, 2013;79:221–9
   Web of Science ®Google Scholar
• Chen YM, Tang M, Chen YP. Recrystallization and micronization of sulfathiazole by applying the supercritical antisolvent technology. Chem Eng J, 2010;165:358–64
   Web of Science ®Google Scholar
• Cheng H, Sutton SC, Pipikin JD, Zentner GM, Rogers JD, Schwartz JI, Mitchel YB, Grasing K, Schwartz MS, Amin, RD, et al. Evaluation of sustained/controlled-release dosage forms of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor in dogs and humans. Pharm Res, 1993;10:1683–7
   PubMed Web of Science ®Google Scholar
• Day CY, Chang CJ, Chen CY. Phase equilibrium of ethanol +CO2 and acetone +CO2 at elevated pressures. J Chem Eng Data, 1996;41:839–43
   Web of Science ®Google Scholar
• Dixit RP, Nagarsenker MS. In vitro and in vivo advantage of celecoxib surface solid dispersion and dosage form development. Ind J Pharm Sci, 2007;69:370–7
   Google Scholar
• Elson CE. Tropical oils: Nutritional and scientific issues. Crit Rev Food Sci Nutr, 1992;31:79–102
   PubMed Web of Science ®Google Scholar
• Godkar PB. 1996. Chemistry of lipids, in textbook of medical laboratory technology. Bombay, India: Bhilani Publishing House
   Google Scholar
• Jun SW, Kim MS, Kim JS, Park HJ, Lee S, Woo JS, Hwang SJ. Preparation and characterization of simvastatin/hydroxypropyl-b-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process. Eur J Pharm Sci, 2007;66:413–21
   Google Scholar
• Jung J, Perrut M. Particle design using supercritical fluids: Literature and patent survey. J Supercrit Fluids, 2001;20:179–219
   Web of Science ®Google Scholar
• Kang BK, Lee JS, Chon SK, Jeong SY, Yuk SH, Khang G, Lee BH, Cho SH. Development of selfmicroemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm, 2004;274:65–73
   PubMed Web of Science ®Google Scholar
• Kordikowski A, Schenk AP, van Nielen RM, Peters CJ. Volume expansions and vapor-liquid equilibria of binary mixtures of a variety of polar solvents and certain near-critical solvents. J Supercrit Fluids, 1995;8:205–16
   Web of Science ®Google Scholar
• Kulhari H, Pooja D, Prajapati SK, Chauhan AS. Performance evaluation of PAMAM dendrimer based simvastatin formulations. Int J Pharm, 2011;405:203–9
   PubMed Web of Science ®Google Scholar
• McClelland CA, Stubbs RJ, Fix JA, Pogany SA, Zentner GM. Enhancement of 3-hydroxy-3-methylglutaryl-coenzyme A (HMGCoA) reductase inhibitor efficacy through administration of a controlled-porosity osmotic pump dosage form. Pharm Res, 1991;8:873–6
   PubMed Web of Science ®Google Scholar
• Meng J, Zheng L. Application of mixture experimental design to simvastatin apparent solubility predictions in the microemulsifion formed by self-microemulsifying. Drug Dev Ind Pharm, 2007;33:927–31
   PubMed Web of Science ®Google Scholar
• Moshashaee S, Bisrat M, Forbes RT, Nyqvist H, York P. Supercritical fluid processing of proteins. I: Lysozyme precipitation from organic solution. Eur J Pharm Sci, 2000;11:239–45
   PubMed Web of Science ®Google Scholar
• Muller RH, Jacobs C, Kayser O. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Adv Drug Delivery Rev, 2001;47:3–19
   PubMed Web of Science ®Google Scholar
• Oh DJ, Lee BC. Solubility of simvastation and lovastatin in mixtures of dichloromethane and supercritical carbon dioxide. J Chem Eng Data, 2007;52:1273–9
   Web of Science ®Google Scholar
• Pandya P, Gattani S, Jain P, Khirwal L, Surana S. Co-solvent evaporation method for enhancement of solubility and dissolution rate of poorly aqueous soluble drug simvastatin: In vitro–in vivo evaluation. AAPS PharmSciTech, 2008;9:1247–52
   PubMed Web of Science ®Google Scholar
• Patel J, Patil P. Preparation and characterization of amoxicillin mucoadhesive microparticles using solution-enhanced dispersion by supercritical CO2. J Microencapsulation, 2012;29:398–408
   PubMed Web of Science ®Google Scholar
• Patel K, Padhye S, Nagarsenker M. Duloxetine HCl lipid nanoparticles: Preparation, characterization, and dosage form design. AAPS PharmSciTech, 2012;13:125–33
   PubMed Web of Science ®Google Scholar
• Patil P, Patil V, Paradkar A. Formulation of a self-emulsifying system for oral delivery of simvastatin: In vitro and in vivo evaluation. Acta Pharm, 2007;57:111–22
   PubMedGoogle Scholar
• Rehman M, Shekunov BY, York P, Colthorpe P. Solubility and precipitation of nicotinic acid in supercritical carbon dioxide. J Pharm Sci, 2001;90:1570–82
   PubMed Web of Science ®Google Scholar
• Reverchon E, Caputo G, DeMarco I. Role of phase behaviour and atomization in the supercritical antisolvent precipitation. Ind Eng Chem Res, 2003;42:6406–14
   Web of Science ®Google Scholar
• Reverchon E, Della Porta G. Production of antibiotic micro- and nanoparticles by supercritical antisolvent precipitation. Powder Technol, 1999;106:23–9
   Web of Science ®Google Scholar
• Reverchon E, Della Porta G, Falivene MG. Process parameters and morphology in amoxicillin micro and submicro particle generation by supercritical antisolvent precipitation. J Supercrit Fluids, 2000;17:239–48
   Web of Science ®Google Scholar
• Reverchon E. Supercritical antisolvent precipitation of micro- and nanoparticles. J Supercrit Fluids, 1999;15:1–21
   Web of Science ®Google Scholar
• Shekunov BY, York P. Crystallization processes in pharmaceutical technology and drug delivery design. J Cryst Growth, 2000;211:122–6
   Web of Science ®Google Scholar
• Suresh G, Manjunath K, Venkateswarlu V, Satyanarayana V. Preparation, characterization, and in vitro and in vivo evaluation of lovastatin solid lipid nanoparticles. AAPS PharmSciTech, 2007;8:162–70
   Web of Science ®Google Scholar
• Tavares Cardoso MA, Monteiro GA, Cardoso JP, Prazeres TJV, Figueiredo JMF, Martinho JMG, Cabral JMS, Palavra AMF. Supercritical antisolvent micronization of minocycline hydrochloride. J Supercrit Fluids, 2008;44:238–44
   Web of Science ®Google Scholar
• Tenorio A, Gordillo MD, Pereyra CM, Martínez de la Ossa EJ. Controlled submicro particle formation of ampicillin by supercritical antisolvent precipitation. J Supercrit Fluids, 2007;40:308–16
   Web of Science ®Google Scholar
• Tu LS, Dehghani F, Foster NR. Micronization and microencapsulation of pharmaceuticals using a carbon dioxide antisolvent. Powder Technol, 2002;126:134–49
   Web of Science ®Google Scholar
• Tubic-Grozdanis M, Hilfinger JM, Amidon GL, Kim JS, Kijek P, Staubach P, Langguth P. Pharmacokinetics of the CYP 3A substrate simvastatin following administration of delayed versus immediate release oral dosage forms. Pharm Res, 2008;25:1591–600
   PubMed Web of Science ®Google Scholar
• Turk M, Hils P, Helfgen B, Schaber K, Martin HJ, Wahl MA. Micronization of pharmaceutical substances by the rapid expansion of supercritical solutions (RESS): A promising method to improve bioavailability of poorly soluble pharmaceutical agents. J Supercrit Fluids, 2002;22:75–84
   Web of Science ®Google Scholar
• Ungaro F, Giovino C, Catanzano O, Miro A, Mele A, Quaglia F, Rotonda MIL. Use of cyclodextrins as solubilizing agents for simvastatin: Effect of hydroxypropyl-b-cyclodextrin on lactone/hydroxyacid aqueous equilibrium. Int J Pharm, 2011;404:49–56
   PubMedGoogle Scholar
• USP 24/NF 19. 2000. United States Pharmacopeial Convention. Rockville
   Google Scholar
• Vivek K, Reddy H, Murthy RS. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles. AAPS PharmSciTech, 2007;8:16–24
   PubMed Web of Science ®Google Scholar
• Won DH, Kim MS, Lee S, Park JS, Hwang SJ. Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti-solvent precipitation process. Int J Pharm, 2005;301:199–203
   PubMed Web of Science ®Google Scholar
• Zhang Z, Bu H, Gao Z, Huang Y, Gao F, Li Y. The characteristics and mechanism of simvastatin loaded lipid nanoparticles to increase oral bioavailability in rats. Int J Pharm, 2010;394:147–53
   PubMed Web of Science ®Google Scholar